Shopping Cart
Remove All
Your shopping cart is currently empty
Dalbavancin (BI-397), a novel second-generation lipoglycopeptide antibiotic, possesses in vitro activity against a variety of Gram-positive pathogens including methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE),Dalbavancin inhibits Staphylococcus aureus and Bacillus anthracis with MIC90s of 0.06 μg/mL and 0.25 μg/mL, respectively

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $55 | In Stock | In Stock | |
| 5 mg | $129 | In Stock | In Stock | |
| 10 mg | $195 | In Stock | In Stock | |
| 25 mg | $393 | In Stock | In Stock | |
| 50 mg | $591 | In Stock | In Stock | |
| 100 mg | $843 | In Stock | In Stock | |
| 1 mL x 10 mM (in DMSO) | $205 | In Stock | In Stock |
| Description | Dalbavancin (BI-397), a novel second-generation lipoglycopeptide antibiotic, possesses in vitro activity against a variety of Gram-positive pathogens including methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE),Dalbavancin inhibits Staphylococcus aureus and Bacillus anthracis with MIC90s of 0.06 μg/mL and 0.25 μg/mL, respectively |
| Targets&IC50 | S. aureus:0.06 μg/mL (MIC90), Bacillus anthracis:0.25 μg/mL (MIC90) |
| Synonyms | VER-001, VER 001, BI-397, BI397, BI 397, A-A-1 antibiotic |
| Molecular Weight | 1816.71 |
| Formula | C88H100Cl2N10O28 |
| Cas No. | 171500-79-1 |
| Smiles | [H][C@@]1(Oc2c3Oc4ccc(C[C@@]5([H])NC(=O)[C@H](NC)c6ccc(O)c(Oc7cc(O)c(Cl)c(c7)[C@]([H])(NC5=O)C(=O)N[C@]5([H])c(c3)cc2Oc2ccc(cc2Cl)[C@@H](O)[C@]2([H])NC(=O)[C@]([H])(NC5=O)c3ccc(O)c(c3)-c3c(O[C@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]5O)cc(O)cc3[C@H](NC2=O)C(=O)NCCCN(C)C)c6)cc4)O[C@@H]([C@@H](O)[C@H](O)[C@H]1NC(=O)CCCCCCCCC(C)C)C(O)=O |
| Relative Density. | 1.59 g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 100 mg/mL (53.96 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.